Skip to content
AnalystLens
Back to WSTBalance Sheet

West Pharmaceutical Services Long-Term Debt 2009-2026 | WST

Annual FY2009–FY2025 · quarterly through Q3 FY2026

Latest annual · FY2025

$202.8M

+0.1%YoY vs FY2024Source: 10-KFY2025

From $379.1M in FY2009 to $202.8M in FY2025: 0.5× in 16 years.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY26$203M+0.1%$203M+0.1%$203M+0.1%Not reported
FY25$203M−1.7%$203M−1.6%$203M0.0%$203M+0.1%
FY24$206M0.0%$206M+0.1%$203M+33.2%$203M+178.3%
FY23$206M−18.4%$206M−18.4%$152M−27.4%$73M−65.2%
FY22$253M+0.1%$252M+0.1%$209M−0.2%$209M0.0%

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date.

Key Statistics

Trend DirectionStable
CAGR

−4.5%

FY2020
$255.2M
FY2025
$202.8M

5 years selected · on the chart

Long-Term Debt History

Year-over-year comparison from 10-K annual reports

  1. $202.8M
YoY changeLargest recent move+178.3%in FY24Latest +0.1%

1 older move runs past ±150% (largest +178.3%); point at, tap or drag across the bars to read one.

Long-Term Debt, period by period

PeriodValueChangeSource
FY2025$202.8M+0.1%10-K
FY2024$202.6M+178.3%10-K
FY2023$72.8M−65.2%10-K
FY2022$208.9M0.0%flat10-K
FY2021$208.8M−18.2%10-K
FY2020$255.2M−0.8%10-K
FY2019$257.3M+31.3%10-K
FY2018$196.0M−0.5%10-K
FY2017$197.0M−12.9%10-K
FY2016$226.2M−1.2%10-K
FY2015$228.9M−25.8%10-K
FY2014$308.3M−17.5%10-K
FY2013$373.5M−1.4%10-K
FY2012$378.8M+26.6%10-K
FY2011$299.3M−16.4%10-K
FY2010$358.1M−5.5%10-K
FY2009$379.1M—10-K

What is long-term debt?

Long-term debt includes bonds, mortgages, and other borrowings with maturities greater than one year.

What is West Pharmaceutical Services's current long-term debt?

West Pharmaceutical Services (WST) annual long-term debt for 2025 was $202.8M, a 0.10% increase from 2024. West Pharmaceutical Services long-term debt for the quarter ending September 30, 2026 was $202.9M.

What was West Pharmaceutical Services's long-term debt in 2024?

West Pharmaceutical Services annual long-term debt for 2024 was $202.6M, a 178.30% increase from 2023.

What was West Pharmaceutical Services's long-term debt in 2023?

West Pharmaceutical Services annual long-term debt for 2023 was $72.8M, a 65.15% decline from 2022.

What is West Pharmaceutical Services's 5-year long-term debt CAGR?

West Pharmaceutical Services long-term debt grew at a compound annual growth rate (CAGR) of 4.49% from FY2020 to FY2025, going from $255.2M to $202.8M over 5 years.

Company
West Pharmaceutical Services
Ticker
WST
Sector
Healthcare
Industry
Surgical & Medical Instruments & Apparatus